Beijing Strong Biotechnologies,Inc. Company Description

Beijing Strong Biotechnologies,Inc. provides in-vitro diagnostics products and services in the People’s Republic of China and internationally.

The company offers biochemistry reagents, including liver, renal, lipid, cardiac, diabetes, special protein, tumor marker, pancreas, inorganic, inflammation, TDM, and other panels; and coagulation products, such as prothrombin time, activated partial thromboplastin time, thrombin time, and fibrinogen, as well as antithrombin III, von Willebrand factor antigen, protein s activity, protein c, lupus anticoagulant, fibrin degradation products, and d-dimer.

It also provides blood grouping card comprising ABO blood type anti stereotype detection card, DiaClon ABD-confirmation, and DiaClon ABO/D+ reverse grouping for patients; automatic coagulation analyzer, automatic biochemistry analyzer, and automated blood groupings analyzer; and SARS RBD neutralization antibody, SARS total antibody, SARS COV-2 antigen test kit for self testing, and SARS antigen card.

In addition, the company provides technology and document services. It sells its products under the GCELL and Beijing MDC brands.

The company was founded in 2001 and is headquartered in Beijing, the People’s Republic of China.

Beijing Strong Biotechnologies,Inc.

Country	China
Founded	2001
Industry	Diagnostics & Research
Sector	Healthcare
Employees	1,098
CEO	Hongjun Liang

Contact Details

Address: Kuang Yi Building Beijing, 100191 China
Phone	86 10 8201 2486
Website	bsbe.com.cn

Stock Details

Ticker Symbol	300406
Exchange	Shenzhen Stock Exchange
Fiscal Year	January - December
Reporting Currency	CNY
ISIN Number	CNE100001Y26
SIC Code	2836

Key Executives

Name	Position
Hongjun Liang	GM and Vice Chairman
Wei Liu	Chief Financial Officer and Accounting Supervisor
Jian Min Wang	Secretary of the Board of Directors
Yi Zhang	Deputy General Manager
Qinghai Yang	Deputy General Manager
Qixin Lin	Deputy General Manager